Birchview Capital as of June 30, 2025
Portfolio Holdings for Birchview Capital
Birchview Capital holds 71 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 14.9 | $15M | 323k | 46.29 | |
| Kla Corporation Com New (KLAC) | 14.1 | $14M | 16k | 895.74 | |
| Corcept Therapeutics Incorporated (CORT) | 4.9 | $4.9M | 67k | 73.40 | |
| Encana Corporation (OVV) | 4.1 | $4.1M | 108k | 38.05 | |
| ACADIA Pharmaceuticals (ACAD) | 4.0 | $4.1M | 188k | 21.57 | |
| Neurocrine Biosciences (NBIX) | 3.9 | $3.9M | 31k | 125.69 | |
| Phreesia (PHR) | 3.2 | $3.3M | 115k | 28.46 | |
| Prothena Corp SHS (PRTA) | 2.7 | $2.7M | 451k | 6.07 | |
| Protagonist Therapeutics (PTGX) | 2.6 | $2.7M | 48k | 55.27 | |
| Stoke Therapeutics (STOK) | 2.4 | $2.4M | 210k | 11.35 | |
| Aziyo Biologics (ELUT) | 2.3 | $2.3M | 1.2M | 1.98 | |
| Castle Biosciences (CSTL) | 2.2 | $2.3M | 111k | 20.42 | |
| Quidel Corporation | 2.1 | $2.1M | 73k | 28.82 | |
| EQT Corporation (EQT) | 2.0 | $2.0M | 35k | 58.32 | |
| Harrow Health (HROW) | 1.8 | $1.8M | 60k | 30.54 | |
| Novocure Ord Shs (NVCR) | 1.8 | $1.8M | 101k | 17.80 | |
| Axogen (AXGN) | 1.7 | $1.7M | 161k | 10.85 | |
| Biodesix | 1.6 | $1.6M | 5.7M | 0.28 | |
| Travere Therapeutics (TVTX) | 1.5 | $1.5M | 103k | 14.80 | |
| Foghorn Therapeutics (FHTX) | 1.5 | $1.5M | 311k | 4.70 | |
| Alkermes SHS (ALKS) | 1.4 | $1.4M | 50k | 28.61 | |
| Masimo Corporation (MASI) | 1.4 | $1.4M | 8.3k | 168.22 | |
| Uniqure Nv SHS (QURE) | 1.4 | $1.4M | 99k | 13.94 | |
| United Therapeutics Corporation (UTHR) | 1.2 | $1.2M | 4.3k | 287.35 | |
| Docgo (DCGO) | 1.2 | $1.2M | 764k | 1.57 | |
| Treace Med Concepts (TMCI) | 1.0 | $1.0M | 177k | 5.88 | |
| Solid Biosciences Com New (SLDB) | 0.9 | $871k | 179k | 4.87 | |
| Kiniksa Pharmaceuticals | 0.8 | $830k | 30k | 27.67 | |
| Freeport-mcmoran Cl-b CL-B (FCX) | 0.8 | $782k | 18k | 43.35 | |
| Kalvista Pharmaceuticals (KALV) | 0.8 | $757k | 67k | 11.30 | |
| Structure Therapeutics Spons Adr (GPCR) | 0.7 | $747k | 36k | 20.74 | |
| Apogee Therapeutics (APGE) | 0.7 | $695k | 16k | 43.43 | |
| Outset Med | 0.7 | $664k | 35k | 19.21 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $657k | 21k | 31.30 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $655k | 18k | 36.36 | |
| Axsome Therapeutics (AXSM) | 0.6 | $626k | 6.0k | 104.39 | |
| Olema Pharmaceuticals (OLMA) | 0.6 | $571k | 134k | 4.26 | |
| Scholar Rock Hldg Corp (SRRK) | 0.6 | $567k | 16k | 35.42 | |
| Intellia Therapeutics (NTLA) | 0.6 | $563k | 60k | 9.38 | |
| Orthopediatrics Corp. (KIDS) | 0.6 | $559k | 26k | 21.48 | |
| Immunome (IMNM) | 0.6 | $558k | 60k | 9.30 | |
| Xencor (XNCR) | 0.5 | $550k | 70k | 7.86 | |
| Halozyme Therapeutics (HALO) | 0.5 | $520k | 10k | 52.02 | |
| Pacific Biosciences of California (PACB) | 0.5 | $496k | 400k | 1.24 | |
| Inhibrx Biosciences (INBX) | 0.5 | $458k | 32k | 14.27 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.4 | $378k | 8.0k | 47.20 | |
| Alphatec Holdings (ATEC) | 0.4 | $366k | 33k | 11.10 | |
| BioCryst Pharmaceuticals (BCRX) | 0.4 | $358k | 40k | 8.96 | |
| Blueprint Medicines (BPMC) | 0.3 | $346k | 2.7k | 128.18 | |
| Cytokinetics (CYTK) | 0.3 | $330k | 10k | 33.04 | |
| Candel Therapeutics (CADL) | 0.3 | $304k | 60k | 5.06 | |
| Tela Bio (TELA) | 0.3 | $301k | 155k | 1.94 | |
| Cogent Biosciences (COGT) | 0.3 | $287k | 40k | 7.18 | |
| Wave Life Sciences SHS (WVE) | 0.3 | $262k | 40k | 6.50 | |
| 10x Genomics Cl A Com (TXG) | 0.3 | $255k | 22k | 11.58 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $242k | 14k | 17.31 | |
| Phathom Pharmaceuticals (PHAT) | 0.2 | $240k | 25k | 9.59 | |
| Bridgebio Pharma (BBIO) | 0.2 | $216k | 5.0k | 43.18 | |
| Neuropace (NPCE) | 0.2 | $183k | 16k | 11.14 | |
| Gossamer Bio (GOSS) | 0.2 | $170k | 138k | 1.23 | |
| Amicus Therapeutics (FOLD) | 0.2 | $160k | 28k | 5.73 | |
| Zenas Biopharma (ZBIO) | 0.2 | $160k | 17k | 9.69 | |
| Cullinan Oncology (CGEM) | 0.1 | $151k | 20k | 7.53 | |
| Karyopharm Therapeutics | 0.1 | $121k | 28k | 4.31 | |
| Applied Therapeutics | 0.1 | $87k | 280k | 0.31 | |
| Ventyx Biosciences (VTYX) | 0.1 | $62k | 29k | 2.14 | |
| Inflarx Nv (IFRX) | 0.0 | $40k | 50k | 0.79 | |
| Aptevo Therapeutics Com New | 0.0 | $31k | 10k | 3.05 | |
| Alumis (ALMS) | 0.0 | $30k | 10k | 3.00 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.0 | $20k | 17k | 1.16 | |
| Accelr8 Technology | 0.0 | $2.1k | 325k | 0.01 |